Abstract:Purpose: This study aimed to investigate the relationship between the interferon-gamma (IFN-γ) pathway in different tumor microenvironments (TME) and patients' prognosis, as well as the regulatory mechanisms of this pathway in tumor cells. Methods: Using RNA-seq data from the TCGA database, we analyzed the predictive value of the IFN-γ pathway across various tumors. We employed a univariate Cox regression model to assess the prognostic significance of IFN-γ signaling in different tumor types. Additionally, we analyzed single-cell RNA sequencing (scRNA-seq) data from the Gene Expression Omnibus (GEO) database to examine the distribution characteristics of the IFN-γ pathway and explore its regulatory mechanisms, highlighting how IFN-γ influenced cellular interactions within the TME. Results: Our analysis revealed a significant association between the IFN-γ pathway and adverse prognosis in pan-cancer tissues (P < 0.001). Interestingly, this correlation varied regarding positive and negative regulation across different tumor types. Through a detailed examination of scRNA-seq data, we found that the IFN-γ pathway exerted substantial regulatory effects on stromal and immune cells. In contrast, its expression and regulatory patterns in tumor cells exhibited diversity and heterogeneity. Further analysis indicated that the IFN-γ pathway not only enhanced the immunogenicity of tumor cells but also inhibited their proliferation. Cell-cell interaction analysis confirmed the pivotal role of the IFN-γ pathway within the overall regulatory network. Moreover, we identified HMGB2 (high mobility group box 2) in T cells as a potential key regulator of tumor cell proliferation. Conclusions: The IFN-γ pathway exhibited a dual function by both suppressing tumor cell proliferation and enhancing their immunogenicity, positioning it as a pivotal target for refined cancer diagnosis and cancer strategies.

IFN-γ Induces Epithelial-to-mesenchymal Transition of Cancer Cells Via an Unique Microrna Processing

IFN-r-induced IFIT5 promotes epithelial-to-mesenchymal transition in prostate cancer via microRNA processing.

Ifn Gamma-Induced Ifit5 Promotes Epithelial-To-Mesenchymal Transition In Prostate Cancer Via Mirna Processing

Interferon-induced IFIT5 Promotes Epithelial-to-mesenchymal Transition Leading to Renal Cancer Invasion.

IFN-γ Induces the Upregulation of RFXAP Via Inhibition of Mir-212-3p in Pancreatic Cancer Cells: A Novel Mechanism for IFN-γ Response.

Targeting MDK Abrogates IFN-γ-Elicited Metastasis inCancers of Various Origins

Low-dose IFN-γ induces tumor cell stemness in tumor microenvironment of non-small cell lung cancer

Specific Expression of Interferon-γ Induced by Synergistic Activation Mediator-Derived Systems Activates Innate Immunity and Inhibits Tumorigenesis.

MicroRNA-182 Targets SMAD7 to Potentiate TGFβ-induced Epithelial-Mesenchymal Transition and Metastasis of Cancer Cells.

Roles of IFN-γ in tumor progression and regression: a review

Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non–Small Cell Lung Cancer

Interferon-gamma signaling promotes melanoma progression and metastasis

The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression

Interferon‐γ Inducible Protein 30 Promotes the Epithelial–mesenchymal Transition‐like Phenotype and Chemoresistance by Activating EGFR/AKT/GSK3β/β‐catenin Pathway in Glioma

Interferon- inducible protein 30 promotes the epithelial-mesenchymal transition-like phenotype and chemoresistance by activating EGFR/AKT/GSK3/-catenin pathway in glioma

Single-cell transcriptomic sequencing analysis of mechanistic insights into the IFN-γ signaling pathway in different tumor cells

Dysregulation in IFN-γ signaling and response: the barricade to tumor immunotherapy

Interferon gamma induces higher neutrophil extracellular traps leading to tumor-killing activity in microsatellite stable colorectal cancer

IFN-γ Inhibits Gastric Carcinogenesis by Inducing Epithelial Cell Autophagy and T-cell Apoptosis.

miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling

The Diverse Pancreatic Tumor Cell-Intrinsic Response to IFNγ is Determined by Epigenetic Heterogeneity.